19-13207858-CCTGCTGCTGCTGCTGCTGCTGCTGCTGCTG-CCTGCTGCTGCTGCTGCTGCTGCTGCTGCTGCTG

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The NM_001127222.2(CACNA1A):​c.6973_6975dupCAG​(p.Gln2325dup) variant causes a conservative inframe insertion change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.034 ( 152 hom., cov: 0)
Exomes 𝑓: 0.039 ( 283 hom. )

Consequence

CACNA1A
NM_001127222.2 conservative_inframe_insertion

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.00

Publications

10 publications found
Variant links:
Genes affected
CACNA1A (HGNC:1388): (calcium voltage-gated channel subunit alpha1 A) Voltage-dependent calcium channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, and gene expression. Calcium channels are multisubunit complexes composed of alpha-1, beta, alpha-2/delta, and gamma subunits. The channel activity is directed by the pore-forming alpha-1 subunit, whereas, the others act as auxiliary subunits regulating this activity. The distinctive properties of the calcium channel types are related primarily to the expression of a variety of alpha-1 isoforms, alpha-1A, B, C, D, E, and S. This gene encodes the alpha-1A subunit, which is predominantly expressed in neuronal tissue. Mutations in this gene are associated with 2 neurologic disorders, familial hemiplegic migraine and episodic ataxia 2. This gene also exhibits polymorphic variation due to (CAG)n-repeats. Multiple transcript variants encoding different isoforms have been found for this gene. In one set of transcript variants, the (CAG)n-repeats occur in the 3' UTR, and are not associated with any disease. But in another set of variants, an insertion extends the coding region to include the (CAG)n-repeats which encode a polyglutamine tract. Expansion of the (CAG)n-repeats from the normal 4-18 to 21-33 in the coding region is associated with spinocerebellar ataxia 6. [provided by RefSeq, Jul 2016]
CACNA1A Gene-Disease associations (from GenCC):
  • episodic ataxia type 2
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Illumina
  • developmental and epileptic encephalopathy, 42
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • migraine, familial hemiplegic, 1
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • spinocerebellar ataxia type 6
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet
  • benign paroxysmal torticollis of infancy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial or sporadic hemiplegic migraine
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Lennox-Gastaut syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 19-13207858-C-CCTG is Benign according to our data. Variant chr19-13207858-C-CCTG is described in ClinVar as [Likely_benign]. Clinvar id is 235603.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.133 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1ANM_001127222.2 linkc.6973_6975dupCAG p.Gln2325dup conservative_inframe_insertion Exon 47 of 47 ENST00000360228.11 NP_001120694.1 O00555-8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1AENST00000360228.11 linkc.6973_6975dupCAG p.Gln2325dup conservative_inframe_insertion Exon 47 of 47 1 NM_001127222.2 ENSP00000353362.5 O00555-8
CACNA1AENST00000638029.1 linkc.6991_6993dupCAG p.Gln2331dup conservative_inframe_insertion Exon 48 of 48 5 ENSP00000489829.1 A0A087WW63
CACNA1AENST00000573710.7 linkc.6979_6981dupCAG p.Gln2327dup conservative_inframe_insertion Exon 47 of 47 5 ENSP00000460092.3 A0A1C7CYY9
CACNA1AENST00000635727.1 linkc.6976_6978dupCAG p.Gln2326dup conservative_inframe_insertion Exon 47 of 47 5 ENSP00000490001.1 A0A1B0GU81
CACNA1AENST00000637769.1 linkc.6976_6978dupCAG p.Gln2326dup conservative_inframe_insertion Exon 47 of 47 1 ENSP00000489778.1 A0A1B0GTN7
CACNA1AENST00000636012.1 linkc.6940_6942dupCAG p.Gln2314dup conservative_inframe_insertion Exon 46 of 46 5 ENSP00000490223.1 A0A1B0GUS3
CACNA1AENST00000637736.1 linkc.6835_6837dupCAG p.Gln2279dup conservative_inframe_insertion Exon 46 of 46 5 ENSP00000489861.1 A0A1B0GTW2
CACNA1AENST00000636768.2 linkn.*1234_*1236dupCAG non_coding_transcript_exon_variant Exon 45 of 45 5 ENSP00000490190.2 A0A1B0GUP3
CACNA1AENST00000713789.1 linkn.*2152_*2154dupCAG non_coding_transcript_exon_variant Exon 47 of 47 ENSP00000519091.1
CACNA1AENST00000636389.1 linkc.*59_*61dupCAG 3_prime_UTR_variant Exon 47 of 47 5 ENSP00000489992.1 A0A1B0GU74
CACNA1AENST00000637432.1 linkc.*185_*187dupCAG 3_prime_UTR_variant Exon 48 of 48 5 ENSP00000490617.1 O00555-2
CACNA1AENST00000635895.1 linkc.*185_*187dupCAG 3_prime_UTR_variant Exon 47 of 47 5 ENSP00000490323.1 A0A384DVW2
CACNA1AENST00000638009.2 linkc.*185_*187dupCAG 3_prime_UTR_variant Exon 47 of 47 1 ENSP00000489913.1 O00555-3
CACNA1AENST00000637276.1 linkc.*185_*187dupCAG 3_prime_UTR_variant Exon 46 of 46 5 ENSP00000489777.1 O00555-5
CACNA1AENST00000636768.2 linkn.*1234_*1236dupCAG 3_prime_UTR_variant Exon 45 of 45 5 ENSP00000490190.2 A0A1B0GUP3
CACNA1AENST00000713789.1 linkn.*2152_*2154dupCAG 3_prime_UTR_variant Exon 47 of 47 ENSP00000519091.1
CACNA1AENST00000636549.1 linkc.*185_*187dupCAG downstream_gene_variant 5 ENSP00000490578.1 B5TYJ1
CACNA1AENST00000637927.1 linkc.*185_*187dupCAG downstream_gene_variant 5 ENSP00000489715.1 A0A1B0GTI4

Frequencies

GnomAD3 genomes
AF:
0.0341
AC:
5032
AN:
147772
Hom.:
153
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.0122
Gnomad AMI
AF:
0.0190
Gnomad AMR
AF:
0.0678
Gnomad ASJ
AF:
0.0215
Gnomad EAS
AF:
0.142
Gnomad SAS
AF:
0.0168
Gnomad FIN
AF:
0.0179
Gnomad MID
AF:
0.0300
Gnomad NFE
AF:
0.0363
Gnomad OTH
AF:
0.0332
GnomAD2 exomes
AF:
0.0572
AC:
2976
AN:
52038
AF XY:
0.0538
show subpopulations
Gnomad AFR exome
AF:
0.00812
Gnomad AMR exome
AF:
0.0971
Gnomad ASJ exome
AF:
0.0213
Gnomad EAS exome
AF:
0.193
Gnomad FIN exome
AF:
0.0295
Gnomad NFE exome
AF:
0.0482
Gnomad OTH exome
AF:
0.0539
GnomAD4 exome
AF:
0.0393
AC:
50492
AN:
1283302
Hom.:
283
Cov.:
0
AF XY:
0.0390
AC XY:
24609
AN XY:
631626
show subpopulations
African (AFR)
AF:
0.0128
AC:
318
AN:
24920
American (AMR)
AF:
0.0725
AC:
1747
AN:
24082
Ashkenazi Jewish (ASJ)
AF:
0.0185
AC:
402
AN:
21716
East Asian (EAS)
AF:
0.115
AC:
3411
AN:
29552
South Asian (SAS)
AF:
0.0211
AC:
1381
AN:
65546
European-Finnish (FIN)
AF:
0.0245
AC:
820
AN:
33408
Middle Eastern (MID)
AF:
0.0371
AC:
139
AN:
3750
European-Non Finnish (NFE)
AF:
0.0392
AC:
40227
AN:
1027206
Other (OTH)
AF:
0.0385
AC:
2047
AN:
53122
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
2535
5069
7604
10138
12673
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1600
3200
4800
6400
8000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0340
AC:
5023
AN:
147874
Hom.:
152
Cov.:
0
AF XY:
0.0350
AC XY:
2519
AN XY:
71986
show subpopulations
African (AFR)
AF:
0.0122
AC:
490
AN:
40202
American (AMR)
AF:
0.0675
AC:
1010
AN:
14962
Ashkenazi Jewish (ASJ)
AF:
0.0215
AC:
74
AN:
3436
East Asian (EAS)
AF:
0.141
AC:
681
AN:
4814
South Asian (SAS)
AF:
0.0168
AC:
79
AN:
4702
European-Finnish (FIN)
AF:
0.0179
AC:
178
AN:
9950
Middle Eastern (MID)
AF:
0.0290
AC:
8
AN:
276
European-Non Finnish (NFE)
AF:
0.0363
AC:
2419
AN:
66594
Other (OTH)
AF:
0.0328
AC:
67
AN:
2042
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
219
437
656
874
1093
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
56
112
168
224
280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0134
Hom.:
195

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Oct 09, 2015
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 21, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Episodic ataxia type 2;C4310716:Developmental and epileptic encephalopathy, 42 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Spinocerebellar ataxia type 6;C1720416:Episodic ataxia type 2;C1832884:Migraine, familial hemiplegic, 1;C4310716:Developmental and epileptic encephalopathy, 42 Benign:1
Apr 07, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.0
Mutation Taster
=81/19
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs16054; hg19: chr19-13318672; COSMIC: COSV64203637; COSMIC: COSV64203637; API